From USFDA
Granules India announced that the USFDA has approved its Abbreviated New Drug Applications (ANDA) for Methylergonovine 0.2 mg Tablets. The AN DA was filed by Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India. The approved ANDA is the bioequivalent to the reference listed drug product (RLD), Methergine 0.2 MG.Methylergonovine is a semisynthetic ergot alkaloid used for the prevention and control of postpartum haemorrhage.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
